| http://www.w3.org/ns/prov#value | - The mortality benefit in the Gambian study was not evident only within 1 week of vaccination, but in fact mainly from 12 months onward when 238 (72.1%) of the 330 PCV-recipients' deaths and 289 (73.5%) of the placebo recipients' deaths occurred.14 The rate of mortality within 7 days of any dose of study vaccine (n = 12; 0.15%) and placebo (n = 15; 0.18%; P = 0.55) did not differ between the two gr
|
